Tag: NanoViricides Inc
NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2...
NanoViricides, Inc. (NYSE American:NNVC) (the Company) reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with...